CoChat

5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

5-Azacytidine is a cytidine analogue that is capable of activating repressed genes in tissue-culture cells and has been shown to increase hemoglobin-F production in anemic baboons. This drug was administered to a patient with severe beta-thalassemia in an attempt to stimulate hemoglobin-F production. After seven days of 5-azacytidine treatment, gamma-globin synthesis increased approximately sevenfold, temporarily normalizing the patient's unbalanced globin synthesis. Erythropoiesis became more effective, leading to a temporary increase in the absolute reticulocyte count (from 5000 to 22,000 per cubic millimeter) and in hemoglobin concentration (from 8.0 to 10.8 g per deciliter). Hypomethylation of bone-marrow DNA near both the gamma-globin and epsilon-globin genes was directly demonstrated. At the time of peak drug effect, about 7000 gamma-globin messenger RNA molecules were present per erythroid bone-marrow cell, in contrast to 10 to 15 epsilon-globin messenger RNA molecules per cell. 5-Azacytidine selectivity increases gamma-globin synthesis and therefore provides a new approach to the treatment of severe beta-thalassemia. Further studies will be required to evaluate the efficacy, risks, and long-term toxicity of 5-azacytidine (or related compounds) before this approach can be used as a therapy for patients with disorders of hemoglobin synthesis.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198212093072401

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

See all 490

Metadata

Authors
Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W.
Venue
New England Journal of Medicine
Published
1982-12-09
Volume
307
Issue
24
Pages
1469-1475
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2318281771
Cited by
490
References
34
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 12 · 2022: 1 · 2021: 8 · 2020: 13 · 2019: 5 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 12 · 2014: 13 · 2013: 10 · 2012: 8
FWCI
36.18
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
Keywords
azacitidine, beta-thalassemia, fetal hemoglobin, DNA hypomethylation, globin gene regulation, erythropoiesis, reticulocyte count, hemoglobin levels, cytidine analogues, hemoglobin synthesis disorders
MeSH terms
Adult, Azacitidine, DNA, Erythropoiesis, Gene Expression Regulation, Globins, Hemoglobins, Humans, Male, Methylation, RNA, Messenger, Stimulation, Chemical, Thalassemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia. https://app.cochat.ai/papers/10.1056/nejm198212093072401
The paper
Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W. (1982). 5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia. New England Journal of Medicine. https://doi.org/10.1056/nejm198212093072401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.